Intimation regarding allotment of 80,872 Equity Shares under Mankind Employee Stock Option Plan 2022
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Mankind Pharma's Nomination and Remuneration Committee has allotted 80,872 equity shares to an eligible employee who exercised their stock options under the ESOP Plan 2022. The shares have a face value of ₹1 each and were issued at exercise prices of ₹860 per share (for 73,372 shares) and ₹1,600 per share (for 7,500 shares). Following this allotment, the company's paid-up share capital has increased from 412,828,328 to 412,909,200 equity shares. The new shares will rank pari-passu with existing equity shares.
This is a routine ESOP exercise with minimal dilution impact (0.02% increase in share capital). No significant shareholder or stock price impact expected, as shares are being issued to employees exercising vested options.